CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 903 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02086500
NCT02086500Phase 3Completed
CompareCT.gov

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial For Trauma Patients At Risk Of Hemorrhage (STAAMP Trial); Phase III Multicenter, Prospective, Randomized, Double Blind, Interventional Trial

Jason Sperry·interventional·Posted Mar 13, 2014·Updated Sep 10, 2020

In Brief

A Phase 3 clinical trial evaluating Tranexamic Acid and Saline control for Traumatic Hemorrhage. Completed, enrolled 903 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if 1 gram of prehospital tranexamic acid given during emergency medical transport to a level 1 trauma center in patients at risk of hemorrhage is associated with lower 30 day mortality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Hemorrhage
CountriesUnited States
CollaboratorsUniversity of Arizona, The University of Texas at San Antonio, University of Utah

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 13, 2014
Enrollment StartJul 1, 2015
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.3 years ago

Interventions

Tranexamic Aciddrug

1 gram of prehospital Tranexamic Acid

Saline controlother

Saline Control